Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. - Wikidata - awgldk - TriplyDB

Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

http://www.wikidata.org/entity/Q35845347

about

Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machinery HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription Requirement for SWI/SNF chromatin-remodeling complex in Tat-mediated activation of the HIV-1 promoter Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid Targeted DNA mutagenesis for the cure of chronic viral infections Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter Characterization of a human RPD3 ortholog, HDAC3 Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence SIRT1 regulates HIV transcription via Tat deacetylation Epigenetic control of HIV-1 post integration latency: implications for therapy Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure Impact of Chromatin on HIV Replication Manipulation of the host protein acetylation network by human immunodeficiency virus type 1 Redefining the viral reservoirs that prevent HIV-1 eradication Bromodomain proteins in HIV infection Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure The immunological synapse: the gateway to the HIV reservoir Recent developments in human immunodeficiency virus-1 latency research Chromatin, non-coding RNAs, and the expression of HIV Understanding HIV latency: the road to an HIV cure A gene related to yeast HOS2 histone deacetylase affects extracellular depolymerase expression and virulence in a plant pathogenic fungus The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner Latency reversal and viral clearance to cure HIV-1.Eradication therapies for HIV Infection: time to begin again.Prospects for treatment of latent HIV.Recruitment and activation of RSK2 by HIV-1 Tat Control of stochastic gene expression by host factors at the HIV promoter.Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.CpG methylation controls reactivation of HIV from latency.Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides.Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.

P2860

Q21296850-3B1975E1-AF08-4AED-8F37-A699364EE582 Q22007982-69E2AE94-0357-4938-AC26-E24027953EDF Q24294385-76D99AAE-40CC-4174-9B58-DCDF7E0A6D87 Q24307870-457AF599-0171-44F1-9338-011977DE0826 Q24315665-557D5118-6BA4-4686-BB8D-13BF553C8DE6 Q24523709-CAD3A711-C52B-4750-8FA8-64BFB14A0A8B Q24525309-CA1657D3-BD8C-47B1-8127-B7C797FFA884 Q24537275-6453A7D0-FF03-47BE-A897-1BD3347F20B4 Q24550742-5DA4A464-4845-4036-8A15-522C63DE99B6 Q24596282-3269CBF2-2F13-473A-8A77-D01F4DE87D21 Q24620150-684803F3-40E9-4F26-9CB6-29F0BE8AFD4A Q24634457-2B2F142E-B348-41E9-AD3C-9DF9D3D7CC54 Q24670403-0FCB86F0-36B2-4429-9E05-154F72A6957C Q24672109-A54856CC-E4DB-42F2-977C-2BF346A25AB8 Q24797263-F6E17ECF-20F8-4430-9B88-89FA182EEFE0 Q26781191-909A10F0-98EB-4F0C-B224-DD891D4DCC74 Q26781275-6E4E99BA-1A87-4BC4-A61D-DF9CD6D80141 Q26782046-3E33E3A3-88B1-4A03-B6FD-82FBBE966FC7 Q26795463-F94B8D3C-6071-4CB2-830C-36BB61C2C9DA Q26827255-1F0AD87F-07EF-4103-91A8-D9A4E564BD62 Q26829860-BF6C323D-3760-49E8-979F-5AE904763FE9 Q26999858-3F9233E3-0AD3-4A2A-A163-ADD22789413C Q27002959-FB8ED846-51EF-4AD4-B604-7D82558EC6E3 Q27013114-42EDDBFD-F232-4D5D-8079-40D6F9F98A4B Q27021127-18D19D50-7479-4462-9AE0-7FAC45374535 Q28085296-A5F364A9-8527-42A0-872A-CAC3C7E966CC Q28343762-90059BF5-2133-49F7-8A77-B5DFEF59B788 Q28361880-3E8FE443-1432-406D-84D0-BEBCCFD0F9AA Q28474468-E1CA95A2-FC21-413E-9D95-6C0258D14B2F Q30248766-0F51EFBA-196C-40BA-9F15-2F1E9CB19EE5 Q30399588-219978CD-CA0C-4914-8133-71E249FD4FD2 Q30424413-EDCD2CAB-027E-4E6F-A034-C200BB975EB2 Q33269333-765A8274-85E2-4A36-AD54-1AFE3DECC9C6 Q33398516-ADB24219-9863-4077-9579-92C44C5ECED5 Q33400343-CD100077-80AD-4E51-8597-FDEC786B70FD Q33476165-0AB655C7-EC57-4D91-8EEA-64039E95989B Q33495565-63385FC3-CD0D-471D-AD19-FD2F0BFD2113 Q33549606-554448EE-4AD3-4902-B5C0-045CB60FA610 Q33582517-879EDEC1-5003-4570-82F6-633231D32A81 Q33602605-B2B57F19-8164-4211-83AC-6066EBDF4AD5

P2860

Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation.

http://www.wikidata.org/entity/Q35845347

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Transcriptional activation and ...... sponse to histone acetylation.

@ast

Transcriptional activation and ...... sponse to histone acetylation.

@en

type

label

Transcriptional activation and ...... sponse to histone acetylation.

@ast

Transcriptional activation and ...... sponse to histone acetylation.

@en

prefLabel

Transcriptional activation and ...... sponse to histone acetylation.

@ast

Transcriptional activation and ...... sponse to histone acetylation.

@en

P1433

Q35845347-FD00DCB9-11C4-415A-AB41-BA604166A410

P1476

Q35845347-B62B97A5-E82F-423A-93F3-9D39CFE1F27F

P2093

Q35845347-0C3CB46C-EFA6-442C-9CF4-FFF4B4B3B798

Q35845347-76E5A640-CCE7-4DA9-A03D-B49BA940CFD8

Q35845347-8107CA7D-5AAF-4903-BB39-463E50C3B6DA

P2860

Q35845347-08AC9871-C4D5-4C91-8F2A-79566460D96B

Q35845347-0B6157AA-6C74-4546-AD66-E396E0F632F0

Q35845347-167575D9-3278-4526-9F22-01862BA363C8

Q35845347-184AC2E0-D0C5-43BE-9CCD-FA8BB6D850BF

Q35845347-26EA8355-9BA2-4A70-89EA-D9B3918FC46C

Q35845347-28001633-3C97-4603-A2CA-BC608D32C9FE

Q35845347-28AFC3EA-4AB7-4D8D-B793-2D36D3283B8C

Q35845347-2B4CD88F-9C32-4AEA-A1C0-A8492D410D68

Q35845347-2D62EC00-923B-478E-8E6A-606526B05355

Q35845347-3BDF5A4D-6A6B-4EE5-AA06-97E266D12725

P304

Q35845347-E0833320-0B03-40CF-A2E4-1562A8DA8996

P31

Q35845347-E588E9B8-D090-4C00-B2F3-6D92FE1FA77C

P407

Q35845347-3419BA8E-8C6F-43AB-B186-AAC3D90E3C9F

P433

Q35845347-E5CFFE79-3A0C-49B2-BBF1-21538E56F94A

P478

Q35845347-2D4D4649-50ED-4905-BB16-867941DC02D0

P50

Q35845347-8BA82AA1-00D5-4E67-860C-0EBC9C213CA3

P577

Q35845347-5ADBBD22-6882-45B2-B74B-C90BAA720733

P698

Q35845347-368EC73D-9438-46B6-949B-5FFB0906D6FC

P932

Q35845347-87263D5A-B17A-4AB2-BB11-1FA68AAEFA74

P1433

The EMBO Journal

P1476

Transcriptional activation and ...... esponse to histone acetylation

@en

P2093

C Van Lint

http://www.w3.org/2001/XMLSchema#string

E Verdin

http://www.w3.org/2001/XMLSchema#string

S Emiliani

http://www.w3.org/2001/XMLSchema#string

P2860

A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B

In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor

Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Direct interaction of human TFIID with the HIV-1 transactivator tat

Cellular transcription factors involved in the regulation of HIV-1 gene expression

Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A

Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

P304

1112-1120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

1996-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8605881

http://www.w3.org/2001/XMLSchema#string

P932

450009

http://www.w3.org/2001/XMLSchema#string